Current Oncology Reports

, Volume 6, Issue 5, pp 329–330

What is the clinically relevant endpoint for cancer prevention trials?

  • Maurie Markman
Editor’s Commentary

DOI: 10.1007/s11912-004-0056-8

Cite this article as:
Markman, M. Curr Oncol Rep (2004) 6: 329. doi:10.1007/s11912-004-0056-8
  • 18 Downloads

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Maurie Markman
    • 1
  1. 1.University of Texas M.D. Anderson Cancer CenterHoustonUSA